Thymoma Clinical Trial - Comparison of Single Port & Two Ports Robotic

Status Recruiting

Clinical Trial Summary

Recently, robotic-assisted thoracic surgery (RATS) has become into as an alternative approach to either, open surgery or video-assisted thoracoscopic surgery. The superiorities of RATS have been reported in series studies, such as intuitive movements, tremor filtration, more degrees of manipulative freedom, motion scaling, and high-definition stereoscopic vision. However, the currently reported robotic thymectomy used 3 ports. Theoretically, less incisions may bring faster postoperative recovery, lighter postoperative pain and higher postoperative quality of life. The investigators have successfully performed robotic thymectomy through 2 ports and even 1 port. However, the potential benefit of less ports robotic thymectomy has not been verified through well-designed cohort study, so this clinical trial has been designed.

Clinical Trial Description

The gold standard technique for thymectomy used to be transsternal approach. Advancements in modern technology bring many evolutions in minimally invasive surgery such as Video-assisted thoracic surgery (VATS) thymectomy gained popularity after 2000s. Recently, robotic-assisted thoracic surgery (RATS) has become into as an alternative approach to either, open surgery or video-assisted thoracoscopic surgery. The superiorities of RATS have been reported in series studies, such as intuitive movements, tremor filtration, more degrees of manipulative freedom, motion scaling, and high-definition stereoscopic vision. However, the currently reported robotic thymectomy used 3 ports. Theoretically, less incisions may bring faster postoperative recovery, lighter postoperative pain and higher postoperative quality of life. The investigators have successfully performed robotic thymectomy through 2 ports and even 1 port. However, the potential benefit of less ports robotic thymectomy has not been verified through well-designed cohort study, so this clinical trial has been designed. ;

Study Design

Related Conditions & MeSH terms

Myasthenia Gravis
Myasthenia Gravis Associated With Thymoma
Thymectomy
Thymoma
Thymus Neoplasms

Clinical Trial Details

NCT number	NCT05262582
Study type	Interventional
Source	Shanghai Pulmonary Hospital, Shanghai, China
Contact	lei jiang, doctor
Phone	+8613917912348
Email	jiangleiem@aliyun.com
Status	Recruiting
Phase	N/A
Start date	May 10, 2022
Completion date	January 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Terminated	`NCT00818090` - Paclitaxel and Cisplatin for Thymic Neoplasm	Phase 2
Completed	`NCT00332969` - Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma	Phase 2
Completed	`NCT00921739` - Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies	Phase 1
Recruiting	`NCT05255965` - IL-8+ naïve T Cells as a Biomarker for Thymoma Identification
Withdrawn	`NCT02948855` - Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
Completed	`NCT00387868` - Preoperative Treatment of Patients With High Risk Thymoma	Phase 2
Completed	`NCT01272817` - Nonmyeloablative Allogeneic Transplant	N/A
Recruiting	`NCT03466827` - Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma	Phase 2
Completed	`NCT02220855` - A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas	Phase 2
Completed	`NCT03288662` - Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors	N/A
Active, not recruiting	`NCT01242072` - Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies	Phase 1
Recruiting	`NCT06029621` - Robot-assisted vs VATS for Thymoma	N/A
Active, not recruiting	`NCT03921671` - Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)	Phase 2
Active, not recruiting	`NCT01621568` - Sunitinib for Advanced Thymus Cancer Following Earlier Treatment	Phase 2
Terminated	`NCT01100944` - A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies	Phase 1/Phase 2
Active, not recruiting	`NCT03968315` - An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma	N/A
Recruiting	`NCT04162691` - Single Cell Sequencing Analysis of Thymoma
Recruiting	`NCT06086327` - Application of 68Ga-Pentixafor PET/CT for Thymoma	Early Phase 1
Completed	`NCT01364727` - A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy — RATS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms